BIOLOGY.DIGITAL
Back to Glossary

21 CFR Part 11 LIMS Compliance

Acronym for: FDA 21 CFR Part 11 / EU Annex 11

Also known as: GxP Electronic Records Validation, ALCOA+ Data Integrity, GLP/GMP Informatics Compliance

The United States Food and Drug Administration (FDA) regulatory standard establishing technical criteria under which electronic laboratory records, LIMS/ELN audit trails, and cryptographic e-signatures are recognized as legally equivalent to paper records in GLP, GCP, and cGMP workflows.

**Quick Spec:** - Term: 21 CFR Part 11 LIMS Compliance - Standard: FDA 21 CFR Part 11 / EU Annex 11 - Where you'll use it in your R&D stack: cGMP Biomanufacturing, GLP Preclinical Toxicology, Clinical Diagnostics (CLIA/CAP) - Platforms we've benchmarked for our readers: Benchling, Sapio Sciences, Dotmatics

Architectural Role in Modern Life Science R&D

Any biotech or pharmaceutical team advancing a candidate from discovery into IND-enabling GLP toxicology, clinical bioanalysis, or cGMP batch release must prove data integrity under ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate). A 21 CFR Part 11 compliant LIMS or ELN enforces immutable, computer-generated, time-stamped audit trails that record the old value, new value, user ID, and reason for change on every assay result. It also requires dual-factor electronic signatures, role-based access control (RBAC), automated session timeouts, and formal Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) validation packages. Why does this matter for your lab? If you're scaling 21 CFR Part 11 LIMS Compliance in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.

Evaluation & Wet-Lab Integration Checklist

How do you evaluate 21 CFR Part 11 LIMS Compliance without wasting six months? Start small. When we audit R&D informatics teams, we tell you to test three things first: prospective wet-lab accuracy (like SPR or Cryo-EM), native API sync with your ELN, and containerized GPU costs. Don't skip the retrospective benchmark. It's the fastest way to see if a vendor's model actually works on your proprietary targets.

Context

Any biotech or pharmaceutical team advancing a candidate from discovery into IND-enabling GLP toxicology, clinical bioanalysis, or cGMP batch release must prove data integrity under ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate). A 21 CFR Part 11 compliant LIMS or ELN enforces immutable, computer-generated, time-stamped audit trails that record the old value, new value, user ID, and reason for change on every assay result. It also requires dual-factor electronic signatures, role-based access control (RBAC), automated session timeouts, and formal Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) validation packages. Why does this matter for your lab? If you're scaling 21 CFR Part 11 LIMS Compliance in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.

Examples

  • 1Configuring Benchling Validated Cloud for GLP bioanalytical ELISA and qPCR assays with mandatory dual-reviewer e-signatures and locked audit logs prior to an FDA IND submission.
  • 2Deploying Sapio Sciences LIMS in a cGMP cell therapy manufacturing facility to track vein-to-vein autologous CAR-T chain of custody and automated certificate of analysis (CoA) release.
  • 3Integrating Agilent OpenLab CDS chromatography data directly into Dotmatics ELN via Allotrope Data Format (ADF) to prevent manual CSV transcription errors during FDA inspection.

Implementing Agents

AI agents that implement or utilize 21 CFR Part 11 LIMS Compliance:

Common Industries

cGMP BiomanufacturingGLP Preclinical ToxicologyClinical Diagnostics (CLIA/CAP)

Related Terms

Learn More

Verified References & Citations (2)

  1. [1]

    FDA guidance on Part 11 Electronic Records and Electronic Signatures scope, audit trail validation, and legacy system controls.

  2. [2]

    EMA EudraLex Volume 4 Annex 11 computerized systems requirements for GMP pharmaceutical manufacturing.

Last updated: March 1, 2026

Ask AI